195 related articles for article (PubMed ID: 27491556)
1. WT1, MSH6, GATA5 and PAX5 as epigenetic oral squamous cell carcinoma biomarkers - a short report.
Ribeiro IP; Caramelo F; Marques F; Domingues A; Mesquita M; Barroso L; Prazeres H; Julião MJ; Baptista IP; Ferreira A; Melo JB; Carreira IM
Cell Oncol (Dordr); 2016 Dec; 39(6):573-582. PubMed ID: 27491556
[TBL] [Abstract][Full Text] [Related]
2. Aberrant methylation of tumour suppressor genes WT1, GATA5 and PAX5 in hepatocellular carcinoma.
Mžik M; Chmelařová M; John S; Laco J; Slabý O; Kiss I; Bohovicová L; Palička V; Nekvindová J
Clin Chem Lab Med; 2016 Dec; 54(12):1971-1980. PubMed ID: 27171388
[TBL] [Abstract][Full Text] [Related]
3. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
[TBL] [Abstract][Full Text] [Related]
4. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
Zhao C; Zou H; Zhang J; Wang J; Liu H
Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
[TBL] [Abstract][Full Text] [Related]
5. Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.
Goel H; Singhal S; Mathur R; Syeda S; Gupta RK; Kumar A; Shrivastava A; Jha AK
Asian Pac J Cancer Prev; 2020 May; 21(5):1283-1287. PubMed ID: 32458634
[TBL] [Abstract][Full Text] [Related]
6. Genomic and epigenetic signatures associated with survival rate in oral squamous cell carcinoma patients.
Ribeiro IP; Caramelo F; Esteves L; Oliveira C; Marques F; Barroso L; Melo JB; Carreira IM
J Cancer; 2018; 9(11):1885-1895. PubMed ID: 29896272
[No Abstract] [Full Text] [Related]
7. Construction of prognostic risk prediction model of oral squamous cell carcinoma based on co-methylated genes.
Zhu Q; Tian G; Gao J
Int J Mol Med; 2019 Sep; 44(3):787-796. PubMed ID: 31198983
[TBL] [Abstract][Full Text] [Related]
8. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
[TBL] [Abstract][Full Text] [Related]
9. Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma.
Yang Z; Liang X; Fu Y; Liu Y; Zheng L; Liu F; Li T; Yin X; Qiao X; Xu X
EBioMedicine; 2019 Sep; 47():44-57. PubMed ID: 31409573
[TBL] [Abstract][Full Text] [Related]
10. Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.
Moelans CB; Verschuur-Maes AH; van Diest PJ
J Pathol; 2011 Oct; 225(2):222-31. PubMed ID: 21710692
[TBL] [Abstract][Full Text] [Related]
11. PAX5 gene as a novel methylation marker that predicts both clinical outcome and cisplatin sensitivity in esophageal squamous cell carcinoma.
Kurimoto K; Hayashi M; Guerrero-Preston R; Koike M; Kanda M; Hirabayashi S; Tanabe H; Takano N; Iwata N; Niwa Y; Takami H; Kobayashi D; Tanaka C; Yamada S; Nakayama G; Sugimoto H; Fujii T; Fujiwara M; Kodera Y
Epigenetics; 2017; 12(10):865-874. PubMed ID: 29099287
[TBL] [Abstract][Full Text] [Related]
12. Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma.
Shen S; Wang G; Shi Q; Zhang R; Zhao Y; Wei Y; Chen F; Christiani DC
Clin Epigenetics; 2017; 9():88. PubMed ID: 28852427
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of tumor-related genes hypermethylation detected in cancer-free surgical margins of oral squamous cell carcinomas.
Supic G; Kozomara R; Jovic N; Zeljic K; Magic Z
Oral Oncol; 2011 Aug; 47(8):702-8. PubMed ID: 21697000
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation in oral squamous cell carcinoma: molecular mechanisms and clinical implications.
González-Ramírez I; García-Cuellar C; Sánchez-Pérez Y; Granados-García M
Oral Dis; 2011 Nov; 17(8):771-8. PubMed ID: 21781230
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the DNMTs mRNA expression and genetic polymorphisms on the clinical outcome in oral cancer patients.
Supic G; Kozomara R; Zeljic K; Jovic N; Magic Z
Clin Oral Investig; 2017 Jan; 21(1):173-182. PubMed ID: 26966018
[TBL] [Abstract][Full Text] [Related]
16. GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma.
Peters I; Gebauer K; Dubrowinskaja N; Atschekzei F; Kramer MW; Hennenlotter J; Tezval H; Abbas M; Scherer R; Merseburger AS; Stenzl A; Kuczyk MA; Serth J
Oncol Rep; 2014 Apr; 31(4):1523-30. PubMed ID: 24549248
[TBL] [Abstract][Full Text] [Related]
17. Validation of methylation markers for diagnosis of oral cavity cancer.
Arantes LM; de Carvalho AC; Melendez ME; Centrone CC; Góis-Filho JF; Toporcov TN; Caly DN; Tajara EH; Goloni-Bertollo EM; Carvalho AL;
Eur J Cancer; 2015 Mar; 51(5):632-41. PubMed ID: 25686481
[TBL] [Abstract][Full Text] [Related]
18. FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?
Russo D; Merolla F; Mascolo M; Ilardi G; Romano S; Varricchio S; Napolitano V; Celetti A; Postiglione L; Di Lorenzo PP; Califano L; Dell'Aversana GO; Astarita F; Romano MF; Staibano S
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218707
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic alterations of the keratin 13 gene in oral squamous cell carcinoma.
Naganuma K; Hatta M; Ikebe T; Yamazaki J
BMC Cancer; 2014 Dec; 14():988. PubMed ID: 25527207
[TBL] [Abstract][Full Text] [Related]
20. Global analysis of DNA methylation changes during progression of oral cancer.
Towle R; Truong D; Hogg K; Robinson WP; Poh CF; Garnis C
Oral Oncol; 2013 Nov; 49(11):1033-42. PubMed ID: 24035722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
